Yano O - Search Results

1

Cloning and sequencing of viral integration site in human fibroblasts immortalized by simian virus 40.

Yano O, Hirano H, Karasaki Y, Higashi K, Nakamura H, Akiya S, Gotoh S. Yano O, et al. Cell Struct Funct. 1991 Feb;16(1):63-71. doi: 10.1247/csf.16.63. Cell Struct Funct. 1991. PMID: 1851675 Free article.

2

Some properties of fibroblasts from a patient with debrancher deficiency.

Furutani A, Yano O, Gotoh S, Higashi K, Hasegawa E, Ohnishi A. Furutani A, et al. Among authors: yano o. J UOEH. 1990 Dec 1;12(4):411-8. doi: 10.7888/juoeh.12.411. J UOEH. 1990. PMID: 2287841

3

[Effects of cadmium on the gene expression of retinoblastoma (Y79) cells in culture].

Murakami T, Yano O, Takahashi H, Akiya S, Higashi K. Murakami T, et al. Among authors: yano o. Nippon Ganka Gakkai Zasshi. 1992 Jun;96(6):737-41. Nippon Ganka Gakkai Zasshi. 1992. PMID: 1626475 Japanese.

4

A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene.

Narasaki F, Oka M, Fukuda M, Nakano R, Ikeda K, Takatani H, Terashi K, Soda H, Yano O, Nakamura T, Doyle LA, Tsuruo T, Kohno S. Narasaki F, et al. Among authors: yano o. Cancer Chemother Pharmacol. 1997;40(5):425-32. doi: 10.1007/s002800050681. Cancer Chemother Pharmacol. 1997. PMID: 9272120

5

Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells.

Baba M, Nakanishi O, Sato W, Saito A, Miyama Y, Yano O, Shimada S, Fukazawa N, Naito M, Tsuruo T. Baba M, et al. Among authors: yano o. Cancer Chemother Pharmacol. 1995;36(5):361-7. doi: 10.1007/BF00686183. Cancer Chemother Pharmacol. 1995. PMID: 7634376

6

DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth.

Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, Tokunaga T. Yamamoto S, et al. Among authors: yano o. Microbiol Immunol. 1992;36(9):983-97. doi: 10.1111/j.1348-0421.1992.tb02102.x. Microbiol Immunol. 1992. PMID: 1281260 Free article.

7

Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer.

Suzuki T, Fukazawa N, San-nohe K, Sato W, Yano O, Tsuruo T. Suzuki T, et al. Among authors: yano o. J Med Chem. 1997 Jun 20;40(13):2047-52. doi: 10.1021/jm960869l. J Med Chem. 1997. PMID: 9207946

8

Reversal of multidrug resistance by a novel quinoline derivative, MS-209.

Sato W, Fukazawa N, Nakanishi O, Baba M, Suzuki T, Yano O, Naito M, Tsuruo T. Sato W, et al. Among authors: yano o. Cancer Chemother Pharmacol. 1995;35(4):271-7. doi: 10.1007/BF00689444. Cancer Chemother Pharmacol. 1995. PMID: 7828268

9

Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.

Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T. Yamamoto S, et al. Among authors: yano o. J Immunol. 1992 Jun 15;148(12):4072-6. J Immunol. 1992. PMID: 1376349

10

Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG.

Kataoka T, Yamamoto S, Yamamoto T, Kuramoto E, Kimura Y, Yano O, Tokunaga T. Kataoka T, et al. Among authors: yano o. Jpn J Cancer Res. 1992 Mar;83(3):244-7. doi: 10.1111/j.1349-7006.1992.tb00094.x. Jpn J Cancer Res. 1992. PMID: 1582885 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters